Sponsor Pipeline

Beijing Shijitan Hospital, Capital Medical University Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
6
Active Trials
5
Recruiting
2
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-08-05 NCT07747701 Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute… Recruiting
Active Trials by Phase
Phase 4
1
Not specified
5
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT06575530 Efficacy and Safety of Remimazolam Besylate for Sedation in Post-Non-Cardiac Surgery… Effect of Drug Recruiting
Not specified
NCT07311421 Raman Spectroscopy-Based Non-Invasive Blood Glucose Detection Diabetes Recruiting
NCT07560280 Evaluation Criteria, Diagnostic Criteria, Surgical Indications, and Establishment of… Jugular Vein Anomaly (Disorder) Recruiting
NCT07556068 Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute… Acute Ischemic Stroke Recruiting
NCT07747701 Ultra-early Identification of Futile Recanalization After Reperfusion Therapy in Acute… Acute Ischemic Stroke Recruiting
NCT06703112 Establishment and Clinical Application of AI-based Multimodal Diagnosis System for… Ovarian Tumors Not Yet Recruiting
Disease Areas
Stroke (2) Diabetes (1)
Get alerts when Beijing Shijitan Hospital, Capital Medical University's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free